align technology is a global medical device company with industry-leading innovative products -- invisalign clear aligners and itero intraoral scanners -- that help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients. invisalign system invisalign clear aligners have been used to straighten teeth and treat minor to complex malocclusion for more than 3 million patients worldwide. the invisalign system is a combination of proprietary virtual modeling software and rapid mass-manufacturing processes used to develop a treatment plan and with custom-made aligners for each patient. invisalign is prescribed to patients through invisalign-trained orthodontists and general practitioner dentists (gp) and is offered in over 90 countries. learn more at www.invisalign.com itero intraoral scanner the itero scanner’s parallel confocal imaging technology uses optical and laser scanning to achieve a high level of precisi
Company profile
Ticker
ALGN
Exchange
Website
CEO
Thomas Prescott
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Edwards Lifesciences • Avanos Medical • MSA Safety • INVACARE • Surgalign • RTI Surgical ...
SEC CIK
Corporate docs
Subsidiaries
Align Technology Switzerland GmbH ...
IRS number
943267295
ALGN stock data
Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
3 May 24
8-K
Align Technology Announces $150 Million Open Market Repurchase
25 Apr 24
8-K
Align Technology Announces First Quarter 2024 Results
24 Apr 24
DEFR14A
Revised proxy
16 Apr 24
ARS
2023 FY
Annual report to shareholders
9 Apr 24
DEFA14A
Additional proxy soliciting materials
9 Apr 24
DEF 14A
Definitive proxy
9 Apr 24
10-K
2023 FY
Annual report
28 Feb 24
8-K
Align Technology Announces Fourth Quarter and Fiscal 2023 Results
31 Jan 24
8-K
Amendments to Articles of Incorporation or Bylaws
16 Jan 24
Transcripts
ALGN
Earnings call transcript
2024 Q1
24 Apr 24
ALGN
Earnings call transcript
2023 Q4
31 Jan 24
ALGN
Earnings call transcript
2023 Q3
25 Oct 23
ALGN
Earnings call transcript
2023 Q2
26 Jul 23
ALGN
Earnings call transcript
2023 Q2
26 Jul 23
ALGN
Earnings call transcript
2023 Q1
26 Apr 23
ALGN
Earnings call transcript
2022 Q4
1 Feb 23
ALGN
Earnings call transcript
2022 Q3
27 Oct 22
ALGN
Earnings call transcript
2022 Q2
27 Jul 22
ALGN
Earnings call transcript
2022 Q1
27 Apr 22
Latest ownership filings
4/A
JOSEPH M HOGAN
5 Apr 24
4/A
John Morici
5 Apr 24
4/A
Julie Ann Coletti
5 Apr 24
4/A
Stuart A Hockridge
5 Apr 24
4/A
Emory Wright
5 Apr 24
SC 13G/A
BlackRock Inc.
7 Mar 24
4
JOSEPH LACOB
29 Feb 24
144
Notice of proposed sale of securities
29 Feb 24
144
Notice of proposed sale of securities
27 Feb 24
4
JOSEPH M HOGAN
22 Feb 24
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 866.88 mm | 866.88 mm | 866.88 mm | 866.88 mm | 866.88 mm | 866.88 mm |
Cash burn (monthly) | 23.88 mm | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 38.02 mm | n/a | n/a | n/a | n/a | n/a |
Cash remaining | 828.86 mm | n/a | n/a | n/a | n/a | n/a |
Runway (months of cash) | 34.7 | n/a | n/a | n/a | n/a | n/a |
Institutional ownership, Q4 2023
58.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 621 |
Opened positions | 73 |
Closed positions | 243 |
Increased positions | 205 |
Reduced positions | 251 |
13F shares | Current |
---|---|
Total value | 11.36 tn |
Total shares | 43.83 mm |
Total puts | 268.67 k |
Total calls | 162.04 k |
Total put/call ratio | 1.7 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 8.35 mm | $2.29 tn |
STT State Street | 3.06 mm | $838.79 bn |
JPM JPMorgan Chase & Co. | 2.27 mm | $622.46 bn |
Wellington Management | 1.80 mm | $493.04 bn |
Brown Advisory | 1.51 mm | $413.49 bn |
Sands Capital Management | 1.43 mm | $391.85 bn |
Polen Capital Management | 1.27 mm | $347.46 bn |
Capital World Investors | 1.26 mm | $344.38 bn |
MS Morgan Stanley | 1.23 mm | $337.47 bn |
BK Bank Of New York Mellon | 1.12 mm | $307.14 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Feb 24 | Lacob Joseph | Common Stock | Sell | Dispose S | Yes | No | 304.7565 | 800 | 243.81 k | 131,994 |
29 Feb 24 | Lacob Joseph | Common Stock | Sell | Dispose S | Yes | No | 303.5899 | 3,676 | 1.12 mm | 132,794 |
29 Feb 24 | Lacob Joseph | Common Stock | Sell | Dispose S | Yes | No | 302.9748 | 10,524 | 3.19 mm | 136,470 |
27 Feb 24 | Lacob Joseph | Common Stock | Sell | Dispose S | Yes | No | 313.0075 | 10,000 | 3.13 mm | 146,994 |
20 Feb 24 | Wright Emory | Common Stock | Payment of exercise | Dispose F | No | No | 313.53 | 1,755 | 550.25 k | 8,294 |
20 Feb 24 | Wright Emory | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,533 | 0.00 | 10,049 |
20 Feb 24 | Wright Emory | Market Stock Unit Common Stock | Grant | Acquire A | No | No | 0.0001 | 4,370 | 0.44 | 4,370 |
20 Feb 24 | Wright Emory | RSU Common Stock | Grant | Acquire A | No | No | 0.0001 | 2,152 | 0.22 | 2,152 |
20 Feb 24 | Wright Emory | Market Stock Unit Common Stock | Option exercise | Dispose M | No | No | 0.0001 | 1,876 | 0.19 | 0 |
20 Feb 24 | Wright Emory | RSU Common Stock | Option exercise | Dispose M | No | No | 0.0001 | 539 | 0.05 | 1,615 |
News
HealthEquity Closes Conduent's BenefitWallet Acquisition
17 May 24
Philips' Gets FDA Recall for Trilogy Ventilator Glitch
15 May 24
Inspire Medical Q1 Earnings Beat, Gross Margin Up
9 May 24
Morgan Stanley Maintains Overweight on Align Tech, Raises Price Target to $360
25 Apr 24
Baird Maintains Outperform on Align Tech, Raises Price Target to $370
25 Apr 24
Press releases
Align Technology to Speak at Upcoming Financial Conferences
13 May 24
Align Technology Announces $150 Million Open Market Repurchase
26 Apr 24
Align Technology Announces First Quarter 2024 Financial Results
24 Apr 24
Align Technology Launches Integrated Consumer Campaign and #Invisisforkids to Drive Awareness of How the Invisalign® Palatal Expander System Is a Better Option for Expanding a Child's Narrow Palate to Make Room for Adult Teeth
8 Apr 24
Invisalign® Palatal Expander System by Align Technology Now Available in Australia and New Zealand for Skeletal and Dental Expansion in Growing Patients
1 Apr 24